Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,764 | 1,934 | 3,879 | 1,292 | 777 |
| Operating Income | -1,764 | -1,934 | -3,879 | -1,292 | -777 |
| Interest Expense | 11 | 628 | 160 | 130 | 176 |
| Other Income | 4 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,772 | -2,562 | -4,039 | -1,422 | -953 |
| Net Income Continuous | -1,772 | -2,562 | -4,039 | -1,422 | -953 |
| Net Income | $-1,772 | $-2,562 | $-4,039 | $-1,422 | $-953 |
| EPS Basic Total Ops | -3.07 | -5.50 | -25.20 | -14.40 | -9.50 |
| EPS Basic Continuous Ops | -3.07 | -5.46 | -25.16 | -14.43 | -9.51 |
| EPS Diluted Total Ops | -3.07 | -5.50 | -25.20 | -14.40 | -9.50 |
| EPS Diluted Continuous Ops | -3.07 | -5.46 | -25.16 | -14.43 | -9.51 |
| EPS Diluted Before Non-Recurring Items | -3.10 | -5.50 | N/A | N/A | N/A |
| EBITDA(a) | $-1,764 | $-1,328 | $-3,758 | $-1,274 | $-760 |